Purchase this report

Cholesterol Lowering Drugs Market 2019 - 2027

(Drug Class: Statins & Combination, PCSK9 Inhibitors, Bile Acid Sequestrants, Fibrates, Cholesterol Absorption Inhibitors, and Others; Indication: Hypercholesterolemia, Coronary Artery Disease, and Higher Triglycerides; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast,

Published	Pages	Publisher	Report code
Jan 2020	196	Transparency Market Research	ASDR-512597

Published: Jan 2020 - Pages : 196 - Publisher : Transparency Market Research - Report code : ASDR-512597

Homozygous Familial Hypercholesterolemia Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F Published: October, 2023 - Pages: 188
Global Hypercholesterolemia Partnering 2014 to 2019 Published: March, 2019 - Pages: 100
Global Metabolic Syndrome Market (2023 Edition): Market Insights and Forecast (2018-2028) Published: June, 2023 - Pages: 270
Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2020 Published: November, 2020 - Pages: 116
Hypercholesterolemia - Pipeline Review, H2 2020 Published: November, 2020 - Pages: 269
Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2019 Published: December, 2019 - Pages: 118
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule ... Published: May, 2022 - Pages: 63
Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorder) - Drugs in Development, 2021 Published: October, 2021 - Pages: 123
Hypercholesterolemia (Metabolic Disorder) - Drugs in Development, 2021 Published: October, 2021 - Pages: 329
Homozygous Familial Hypercholesterolemia (HoFH) (Metabolic Disorders) - Drugs in Development, 2021 Published: April, 2021 - Pages: 50